DEVART Middle East establish great partnership with
Philex pharma by signing a strategic manufacturing contract that
includes manufacture of DEVART Middle East most important products in Philex
pharma factories to enhance DEVART Middle East strong presence in Oman, thus
being a starting point for achieving steps of Philex and DEVART Middle East
common goals in Arab region and East Africa,
Where DEVART Middle East is a leading group specialized
in nutritional supplements and cosmeceuticals. Its main office is in the United
Arab Emirates in Dubai and has a presence in Kingdom of Saudi Arabia and Qatar
with ambitions to expand its activity in Gulf region and East Africa based on
the partnership with Philex Pharma
by this step, DEVART Middle East aims to contribute to
strengthen Arab and Gulf pharmaceutical market by transferring products with
unique manufacturing technology to be available in Gulf region and Africa
through this partnership, which is an essential part of DEVART vision since
2011, in which we believe that DEVART has a very important role apart from
being an entity that contributes to medical community support
Rather, we fully believe that we have a role that goes
beyond supporting society by standing side by side with various national
institutions in facing various challenges
DEVART has previously succeeded in addressing many major
challenges in Egyptian market during past ten years
One of the major challenges that DEVART effectively
contributed to providing medical solutions to it through its distinguished
products in Egyptian market is iron deficiency anemia among two most important
groups of society (pregnant women and children)
by providing completely
different technology and products with high safety and outstanding
effectiveness through many national initiatives Such as “Pregnancy
Without Anemia” and “Childhood Without Pain… Childhood Without Anemia”
and other challenges such as supporting breastfeeding through “Breastfeeding
Support” initiative and providing important products in this field
DEVART Middle East seeks, through the agreement with Philex pharma, to start the repeated success at Arab societies level, especially in Oman and Gulf Cooperation Council countries, and to reach common goals.
